These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30499176)

  • 21. In vivo effects of phenylbutazone on inflammation and cartilage-derived biomarkers in equine joints with acute synovitis.
    de Grauw JC; van Loon JP; van de Lest CH; Brunott A; van Weeren PR
    Vet J; 2014 Jul; 201(1):51-6. PubMed ID: 24888681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The concentration changes of different phenylbutazone formulations in horse plasma].
    Keller H; Hashem A
    Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):224-30. PubMed ID: 8766906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenylbutazone kinetics and metabolite concentrations in the horse after five days of administration.
    Soma LR; Gallis DE; Davis WL; Cochran TA; Woodward CB
    Am J Vet Res; 1983 Nov; 44(11):2104-9. PubMed ID: 6650958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenylbutazone concentrations in synovial fluid following administration via intravenous regional limb perfusion in the forelimbs of six adult horses.
    O'Brien M; Mochel JP; Kersh K; Wang C; Troy J
    Front Vet Sci; 2023; 10():1236976. PubMed ID: 37691633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of concurrent treatment with omeprazole on phenylbutazone-induced equine gastric ulcer syndrome (EGUS).
    Ricord M; Andrews FM; Yñiguez FJM; Keowen M; Garza F; Paul L; Chapman A; Banse HE
    Equine Vet J; 2021 Mar; 53(2):356-363. PubMed ID: 32697849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse.
    Lees P; Taylor JB; Maitho TE; Millar JD; Higgins AJ
    Cornell Vet; 1987 Apr; 77(2):192-211. PubMed ID: 3568689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of intravenous and intragastric cimetidine in horses. I. Effects of intravenous cimetidine on pharmacokinetics of intravenous phenylbutazone.
    Sams RA; Gerken DF; Dyke TM; Reed SM; Ashcraft SM
    J Vet Pharmacol Ther; 1997 Oct; 20(5):355-61. PubMed ID: 9350255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and effects on arachidonic acid metabolism of low doses of cannabidiol following oral administration to horses.
    Ryan D; McKemie DS; Kass PH; Puschner B; Knych HK
    Drug Test Anal; 2021 Jul; 13(7):1305-1317. PubMed ID: 33723919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary investigations of pain and analgesia assessment in horses administered phenylbutazone or placebo after arthroscopic surgery.
    Raekallio M; Taylor PM; Bennett RC
    Vet Surg; 1997; 26(2):150-5. PubMed ID: 9068166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical effects of a combination of phenylbutazone and omeprazole on chronic lameness in Mongolian horses.
    Li Z; Du S; Wang X; Zhang L; Liu X; Fan Q; Yang H; Gao R
    Equine Vet J; 2024 May; 56(3):562-572. PubMed ID: 37337455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of single-dose intravenous phenylbutazone on experimentally induced, reversible lameness in the horse.
    Foreman JH; Barange A; Lawrence LM; Hungerford LL
    J Vet Pharmacol Ther; 2008 Feb; 31(1):39-44. PubMed ID: 18177317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of phenylbutazone given intravenously or orally in mature Holstein bulls.
    Williams RJ; Smith JA; Boudinot FD; Knight AP
    Am J Vet Res; 1990 Mar; 51(3):367-70. PubMed ID: 2316911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of phenylbutazone residues in horse tissues with and without enzyme-hydrolysis by LC-MS/MS.
    Boison JO; Dowling T; Johnson R; Kinar J
    Drug Test Anal; 2016 May; 8(5-6):535-8. PubMed ID: 27443208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of phenylbutazone on bone activity and formation in horses.
    Rohde C; Anderson DE; Bertone AL; Weisbrode SE
    Am J Vet Res; 2000 May; 61(5):537-43. PubMed ID: 10803649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of phenylbutazone in mature Holstein bulls: steady-state kinetics after multiple oral dosing.
    Williams RJ; Boudinot FD; Smith JA; Knight AP
    Am J Vet Res; 1990 Mar; 51(3):371-5. PubMed ID: 2316912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses.
    Foreman JH; Ruemmler R
    Equine Vet J Suppl; 2011 Nov; (40):12-7. PubMed ID: 22082440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of top-dress formulations of suxibuzone and phenylbutazone on development of gastric ulcers in horses.
    Andrews FM; Reinemeyer CR; Longhofer SL
    Vet Ther; 2009; 10(3):113-20. PubMed ID: 20037965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A non-invasive and quantitative method for the study of tissue injury caused by intramuscular injection of drugs in horses.
    Toutain PL; Lassourd V; Costes G; Alvinerie M; Bret L; Lefebvre HP; Braun JP
    J Vet Pharmacol Ther; 1995 Jun; 18(3):226-35. PubMed ID: 7674460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of single-dose intravenous phenylbutazone and flunixin meglumine before, during and after exercise in an experimental reversible model of foot lameness in horses.
    Foreman JH; Grubb TL; Inoue OJ; Banner SE; Ball KT
    Equine Vet J Suppl; 2010 Nov; (38):601-5. PubMed ID: 21059067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary evaluation of hepatitis A virus cell receptor 1/kidney injury molecule 1 in healthy horses treated with phenylbutazone.
    Costa LRR; Swiderski C; Palm C; Aleman M
    J Vet Emerg Crit Care (San Antonio); 2023; 33(4):481-486. PubMed ID: 37436880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.